Company News

QuantRx Biomedical Completes Technology License Agreement

Author Image

By: TOM BRANNA

Editor

QuantRx Biomedical Corporation announced the completion of a Worldwide Technology License Agreement with The Procter & Gamble Company. Walter Witoshkin, President and CEO, stated, “We are pleased to be able to add this significant technology as an expansion to our world-wide intellectual property. With the addition of this key technology to the QuantRx PAD portfolio of products we plan to enter the hemorrhoid treatment market with great confidence in our competitive advantages.&#82...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters